10|1|2018
17:37 Farmaindustria
The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System
3|2|2017
11:47 Farmaindustria
The excellence of the professionals, the quality of the National Health System, the commitment of the industry and the new legal framework, facilitate the clinical research against cancer in Spain
The improvement of the medicines ensures that the healthcare cost of the cancer treatment remains stable despite the increase in the incidence rates
4|1|2017
13:53 Farmaindustria
The agreement is the result of a sustained dialogue and positive experience from the Protocol signed in 2015 and will be in force throughout 2017
29|11|2016
09:26 Farmaindustria
Technical proposal to health authorities to combat the high rate of therapeutic non-compliance and its effects on health
13|7|2016
10:53 Farmaindustria
His Majesty King Felipe VI hosted an audience with Farmaindustria’s Board of Directors
| We innovate for people